SEC Filing Update: #ACRS Aclaris Therapeutics, Inc. : $5.57

Sector: Healthcare | YTD: 🔼+ 92.07% The SEC disclosed Today (21-SEP-2026) that Frazier Life Sciences Public Fund, L.P. has Newly bought 7,879,943 #ACRS shares Ownership: 5.4% * Estimated Investment Value: $43.65M https://www.thinksabio.com/reports/isr/ACRS The quarterly average prices of #ACRS: Q3 2025: $1.75 Q4 2025: $2.52 Q1 2026: $3.38 Q2 2026: $4.46 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2102132239651807479 Frazier Life Sciences Public Fund, L.P. acquired 7,879,943 shares of ACRS, representing a 5.4% ownership stake, according to a 13D/G filing.